Skip to main content

Advertisement

SpringerLink
Log in

ODC MRNA as a Prognostic Factor For Predicting Recurrence in Meningiomas

  • Published:
Journal of Neuro-Oncology Aims and scope Submit manuscript

Abstract

In proliferating neoplastic cells, activity of the enzyme ornithine decarboxylase (ODC) increases. Among other brain tumors, ODC activation could also be observed in meningiomas. In the present study, we have investigated ODC gene expression in primary and recurrent meningiomas at the transcriptional level.

ODC mRNA (messenger ribonucleic acid), ODC activity, number of mitoses, and Ki-67 index as a marker for nuclear proliferation were quantified in three different groups of meningiomas: tumors without recurrence in a 8.4 years median follow-up period, tumors with recurrence within a median follow-up of 3.0 years, and their corresponding recurrent tumors.

ODC mRNA level was significantly higher in meningiomas with later recurrence as compared to meningiomas without recurrence (p ≤ 0.01), whereas it declined in the recurrences of the second group (p ≤ 0.001). In contrast, ODC activity showed no difference between the two groups of primary tumors, but a significant increase of enzyme activity could be observed in the recurrences as compared to the correponding primary tumors (p ≤ 0.001). Likewise, an increase of the Ki-67 index could be detected in the recurrent group (p ≤ 0.001). These results suggest that ODC mRNA may represent a prognostic factor for predicting recurrence in meningiomas.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Russel DS, Rubinstein LJ: Pathology of Tumours of the Nervous System. Edward Arnold, London, 1989, pp 452–506

    Google Scholar 

  2. Penella A, Ferri C, Lettini T, Serio G, Cimmino A, Caniglia DM, Giangaspero F, Ricco R: Atypical meningioma: morphometric analysis of nuclear pleomorphism. Pathologica 92: 25–31, 2000

    Google Scholar 

  3. Abramovich CM, Prayson RA: Histopathologic features and MIB-1 labeling indices in recurrent and nonrecurrent meningiomas. Arch Pathol Lab Med 123: 793–800, 1999

    Google Scholar 

  4. Perry A, Scheithauer BW, Stafford SL, Lohse CM, Wollan PC: Malignancy in meningioms: a clinicopathological study of 116 patients, with grading implications. Cancer 85: 2046–2056, 1999

    Google Scholar 

  5. Mahmood A, Caccamo DV, Tomecek FJ, Malik GM: Atypical and malignant meningiomas: a clinicopathological review. Neurosurgery 33: 955–963, 1993

    Google Scholar 

  6. Perry A, Stafford SL, Scheithauer BW, Suman VJ, Lohse CM: Meningioma grading: an analysis of histologic parameters. Am J Surg Pathol 21: 1455–1465, 1997

    Google Scholar 

  7. Pegg AE, McCann PP: Polyamine metabolism and function. Am J Physiol 243: C212–C221, 1982

    Google Scholar 

  8. Heby O, Persson L: Molecular genetics of polyamine synthesis in eukaryotic cells. Trends Biochem Sci 15: 153–158, 1990

    Google Scholar 

  9. Jänne J, Alhonen L, Leinonen P: Polyamines: from molecular biology to clinical applications. Ann Med 23: 241–259, 1991

    Google Scholar 

  10. Auvinen M, Paasinen A, Andersson LC, Höltta E: Ornithine decarboxylase activity is critical for cell transformation. Nature 360: 355–358, 1992

    Google Scholar 

  11. Scalabrino G, Ferioli ME: Degree of enhancement of polyamine biosynthetic decarboxylase activities in human tumors: A useful new index of degree of malignancy. Cancer Detect Prev 8: 11–46, 1985

    Google Scholar 

  12. Ernestus R-I, Röhn G, Schröder R, Els T, Klekner Á, Paschen W, Klug N: Polyamine metabolism in brain tumors. Diagnostic relevance of quantitative biochemistry. J Neurol Neurosurg Psych 71: 88–92, 2001

    Google Scholar 

  13. Ernestus R-I, Röhn G, Hossmann K-A, Paschen W: Polyamine metabolism in experimental brain tumors of rat. J Neurochem 60: 417–422, 1993

    Google Scholar 

  14. Röhn G, Els T, Hell K, Ernestus R-I: Regional distribution of ornithine decarboxylase activity and polyamine levels in experimental cat brain tumors. Neurochem Int 39: 135–140, 2001

    Google Scholar 

  15. Ernestus R-I, Röhn G, Schröder R, Els T, Lee J-Y, Klug N, Paschen W: Polyamine metabolism in gliomas. J Neuro-Oncol 29: 167–174, 1996

    Google Scholar 

  16. Bachrach U: Polyamines as chemical markers of malignancy. Ital J Biochem 25: 77–93, 1976

    Google Scholar 

  17. Ernestus R-I, Schröder R, Röhn G, Klug N, Hossmann K-A, Paschen W: Activity of ornithine decarboxylase and Ki-67 index in meningiomas. Adv Neurosurg 21: 307–311, 1993

    Google Scholar 

  18. Schröder R, Bien K, Kott R, Meyers I, Vössing R: The relationship between Ki-67 labeling and mitotic index in gliomas and meningiomas: demonstration of the variability of the intermitotic cycle time. Acta Neuropathol 82: 389–394, 1991

    Google Scholar 

  19. Kleihues P, Cavenee WK: Pathology and genetics of tumours of the nervous system. WHO Classification of Tumours. IARC Press, Lyon, 2000

    Google Scholar 

  20. Paschen W, Röhn G, Meese CO, Djuricic B, Schmidt-Kastner R: Polyamine metabolism in reversible cerebral ischemia: effect of α-difluoromethylornithine. Brain Res 453: 9–16, 1988

    Google Scholar 

  21. Colle JH, Falanga PB, Singer M, Hevin B, Milon G: Quantitation of messenger RNA by competitive RT-PCR: a simplified read out assay. J Immun Methods 210: 175–184, 1997

    Google Scholar 

  22. Cheesman MJ, Reilly PEB: Differential inducibility of specific mRNA corresponding to five CYP3A isoforms in female rat liver by RU486 and food deprivation. Biochem Pharm 56: 473–481, 1998

    Google Scholar 

  23. Higuchi R, Krumel B, Saiki RK: Ageneral method of in vitro preparation and specific mutagenesis of DNA fragments: study of protein and DNA interactions. Nucl Acids Res 16: 7351–7367, 1988

    Google Scholar 

  24. Wilson CB: Meningiomas: Genetics, malignancy, and the role of radiation in induction and treatment. J Neurosurg 81: 666–675, 1994

    Google Scholar 

  25. Niedermayer I, Feiden W, Henn W: Loss of alkaline phosphatase activity in meningiomas: a rapid histochemical technique indicating progression-associated deletions on the distal part of the short arm of chromosome 1. J Neuropathol Exp Neurol 56: 879–886, 1997

    Google Scholar 

  26. Weber RG, Boström J, Wolter M, Baudis M, Collins VP, Reifenberger G, Lichter P: Analysis of genomic alterations in benign, atypical, and anaplastic meningiomas: Toward a genetic model of meningioma progression. Proc Natl Acad Sci USA 94: 14719–14724, 1997

    Google Scholar 

  27. Henn W, Urbschat S: Genetische Grundlagen der Entstehung von Hirntumoren. Radiologe 38: 898–903, 1998

    Google Scholar 

  28. Legraverend C, Potter A, Hölttä E, Alitalo K, Andersson LC: Interleukin-2 induces a rapid increase in ornithine decarboxylase mRNA in a cloned murine T lymphocytic cell line. Exp Cell Res 181: 273–281, 1989

    Google Scholar 

  29. Wrighton C, Busslinger M: Direct transcriptional stimulation of the ornithine decarboxylase gene by fos in PC12 cells but not in fibroblasts. Mol Cell Biol 13: 4657–4669, 1993

    Google Scholar 

  30. Pegg AE: Polyamine metabolism and its importance in neoplastic growth and as a target for chemotherapy. Cancer Res 48: 759–774, 1988

    Google Scholar 

  31. Katz A, Kahana C: Transcriptional activation of mammalian ornithine decarboxylase during stimulated growth. Mol Cell Biol 7: 2641–2643, 1987

    Google Scholar 

  32. Horn Y, Beal ST, Walach N, Lubich WP, Spigel L, Marton LJ: Further evidence for use of polyamines as biochemical markers for malignant tumors. Cancer Res 42: 3248–3251, 1982

    Google Scholar 

  33. Russel DH: Clinical relevance of polyamines. Crit Rev Clin Lab Sci 18: 261–311, 1983

    Google Scholar 

  34. Hayashi S, Murakami Y: Rapid and regulated degradation of ornithine decarboxylase. Biochem J 306: 1–10, 1995

    Google Scholar 

  35. Murakami Y, Matsufuji S, Miyazaki Y, Hayashi S: Forced expression of antizyme abolishes ornithine decarboxylase activity, suppresses cellular levels of polyamines and inhibits cell growth. Biochem J 364: 183–187, 1994

    Google Scholar 

  36. Shantz LM, Pegg AE: Translational regulation of ornithine decarboxylase and other enzymes of the polyamine pathway. Int J Biochem Cell Biol 31: 107–122, 1999

    Google Scholar 

  37. Wetters TD, Macre M, Brabant M, Sittler A, Coffino P: Polyamine-mediated regulation of mouse ornithine decarboxylase is posttranslational. Mol Cell Biol 9: 5484–5490, 1989

    Google Scholar 

  38. Elitsur Y, Moshier JA, Murthy R, Barbish A, Luk GD: Polyamine levels, ornithine decarboxylase (ODC) activity, and ODC-mRNA expression in normal and cancerous human colonocytes. Life Sci 50: 1417–1424, 1992

    Google Scholar 

  39. Mafune K, Tanaka Y, Mimori K, Mori M, Takubo K, Makuuchi M: Increased expression of ornithine decarboxylase messenger RNA in human esophageal carcinoma. Clin Cancer Res 5: 4073–4078, 1999

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurosurgery, University of Cologne, Cologne, Germany

    Álmos Klekner, Gabriele Röhn, Gerhard Schillinger, Norfrid Klug & Ralf-Ingo Ernestus

  2. Department of Neuropathology, University of Cologne, Cologne, Germany

    Roland Schröder

Authors
  1. Álmos Klekner
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Gabriele Röhn
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Gerhard Schillinger
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Roland Schröder
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Norfrid Klug
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Ralf-Ingo Ernestus
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Klekner, Á., Röhn, G., Schillinger, G. et al. ODC MRNA as a Prognostic Factor For Predicting Recurrence in Meningiomas. J Neurooncol 53, 67–75 (2001). https://doi.org/10.1023/A:1011878928318

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1011878928318

Search

Navigation